GLP1R and obesity due to melanocortin 4 receptor deficiency: By activating GLP-1, GIP, and glucagon receptors, it exerts effects across multiple metabolic pathways, regulating appetite, energy expenditure, and glucose homeostasis, which may provide enhanced efficacy, particularly in patients with obesity and T2DM.